Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

First Page		Document Content
Date: 2015-05-13 10:22:10 Choroidal neovascularization Ranibizumab Macular degeneration Vision Maculopathy Vascular endothelial growth factor Myopia Genentech Macular edema Ophthalmology Medicine Health		Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca Add to Reading List Source URL: www.novartis.ca Download Document from Source Website File Size: 209,53 KB Share Document on Facebook

	CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for DocID: 1pDeC - View Document
	LABORATORY SCIENCES Preclinical Evaluation of the Novel Small-Molecule Integrin ␣5␤1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization Grit Zahn, PhD; Dörte Vossmeyer, PhD; Roland Stragi DocID: 1lkvp - View Document
	PRESTATIE- EN TARIEFBESCHIKKING ADD-ON RANIBIZUMAB Nummer Datum inwerkingtreding DocID: 1cIqP - View Document
	FOR IMMEDIATE RELEASE Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals Seasoned Executive Brings Wealth of Experience to Ophthalmic Biotechnology Pioneer, Including Leadership of SARcode Bio DocID: 1a9Xb - View Document
	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca DocID: 19zgB - View Document